Biopsia estereotáctica cerebral guiada por tomografía: análisis de 65 casos
Palabras clave:
biopsia estereotáctica cerebral, hemorragia cerebral,, hemorragia intracraneal, complicacionesResumen
Objetivo: analizar retrospectivamente las características demográficas, topografía lesional, resultados anatomopatológicos y complicaciones de una serie de 65 biopsias estereotácticas cerebrales guiadas por tomografía.
Materiales y métodos: estudio retrospectivo de 65 pacientes sometidos a 65 biopsias cerebrales estereotácticas guiadas con tomografía, desde enero 2012 hasta diciembre 2016, en el Hospital Carlos Andrade Marín (Quito-Ecuador).
Resultados: se analizaron 65 pacientes con edad promedio de 48 años (rango: 15 a 78 años); 42 pacientes fueron hombres (64,61%) y 23 mujeres (35,38%). 54 pacientes (83%) presentaron lesiones únicas y 11 (17%) múltiples.
El porcentaje de resultados positivos fue de 80%; de los cuales, 76,92% correspondieron a patología tumoral, de ellos 69,23% fueron primarios del SNC y 7,69% fueron metástasis. Se registró 10,76% de complicaciones hemorrágicas asintomáticas y 9,23% de morbilidad registrada como transitoria. No se reportó infecciones del sitio quirúrgico ni infección post-operatoria relacionados con los cuidados de la salud. No registramos mortalidad.
Conclusiones: la biopsia estereotáctica cerebral guiada por tomografía es una herramienta mínimamente invasiva, segura y eficaz para el diagnóstico anatomopatológico definitivo. La complicación prevalente en esta serie fue la hemorragia post-biopsia; sin embargo, fue asintomática y no alteró la evolución de los pacientes; el resto de complicaciones correspondió a morbilidad transitoria. No registramos infección post-operatoria ni mortalidad.
Descargas
Citas
Sawin PD, Hitchon PW, Follett KA, Torner JC. Computed imagingassisted stereotactic brain biopsy: a risk analysis of 225 consecutive cases. Surg Neurol 1998;49:640-649.
Yamada K, Goto S, Kochi M, Ushio Y. Stereotactic biopsy for multifocal, diffuse, and deep-seated brain tumors using Leksell’s system. J Clin Neurosci 2004;11:263-267.
Yu X, Liu Z, Tian Z, Li S, Huang H, Xiu B, et al. Stereotactic biopsy for intracranial space-occupying lesions: clinical analysis of 550 cases. Stereotact Funct Neurosurg 2000;75:103-108.
Apuzzo ML, Chandrasoma PT, Cohen D, Zee CS, Zelman V. Computed imaging stereotaxy: experience and perspective related to 500 procedures applied to brain masses. Neurosurgery 1987;20:930-937.
Dorward NL, Paleologos TS, Alberti O, Thomas DG. The advantages of frameless stereotactic biopsy over frame-based biopsy. Br J Neurosurg 2002;16:110-118.
Ranjan A, Rajshekhar V, Joseph T. Non diagnostic CT-guided stereotactic biopsies in a series of 407 cases: influence of TC morphology and operator experience. J Neurosurg 1993;79:839-844.
Landriel F, Hem S, Hasdeu S, et al. Biopsia estereotáctica cerebral guiada tomográficamente. análisis de una serie de 192 casos. Rev Argent Neuroc 2008;22:110.
Karnofsky DA, Abelmann WH, Lloyd FC, Burchenal JH. The use of the nitrogen mustards in the palliative treatment of carcinoma. With particular reference to bronchogenic carcinoma. Cancer 1948;1(4):634-656.
Ostertag CG, Mennel HD, Kiessling M. Stereotactic biopsy of brain tumors. Surg Neurol 1980;14:275-283.
McGirt MJ, Woodworth GF, Coon AL, Frazier JM, Amundson E,
Garonzik I, Olivi A, Weingart JD. Independent predictors of morbidity after image-guided stereotactic brain biopsy: a risk assessment of 270 cases. J Neurosurg 2005;102:897-901.
Ranjan A, Rajshekhar V, Joseph T. Non diagnostic CT-guided stereotactic biopsies in a series of 407 cases: influence of TC morphology and operator experience. J Neurosurg 1993;79:839-844.
Dammers R, Haitsma IK, Schouten JW, Kros JM, Avezaat CJ, Vincent AJ. Safety and Efficacy of frameless and frame-based intracranial biopsy techniques. Acta Neurochir 2008;150(1):23-29.
Grossman R, Sadetzki S, Spiegelmann R, Ram Z. Haemorrhagic complications and the incidence of asymptomatic bleeding associated with stereotactic brain biopsies. Acta Neurochir 2005;147(6):627-6-31.
Malone H, Yang J, Hershmann DL, et al. Complications following stereotactic needle biopsy of intracranial tumors. World Neurosurgery 2015. (Accepted manuscript).
Hall WA. The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer 1998;82:1749-1755.
Kreth FW, Muacevic A, Medele R, Bise K, Meyer T, Reulen HJ. The risk of haemorrhage after image guided stereotactic biopsy of intra-axial brain tumours - a prospective study. Acta Neurochir 2001;143:539-545-discussion 545-546.
Nishihara M, Sasayama T, Kudo H, Kohmura E. Morbidity of stereotactic biopsy for intracranial lesions. Kobe J Med Sci 2011;56:E148-153.
Livermore LJ, Livermore LJ, Ma R, Ma R, Bojanic S, Bojanic S, et al. Yield and complications of frame-based and frameless stereotactic brain biopsy - The value of intraoperative histological analysis. Br J Neurosurg 2014;28:637-644.
Shad A, Green A, Bojanic S y Aziz T. Awake stereotactic biopsy of brain stem lesions: technique and results. Acta Neurochir (Wien) 2005;147:47-50.
Hood T, Gebarski S, McKeever P, et al. Stereotactic biopsy of intrinsic lesion of the brain stem. J Neurosurg 1986;65:172-176.
Samadani U, Judy KD. Stereotactic brainstem biopsy is indicated for the diagnosis of a vast array of brainstem pathology. Stereotact Funct Neurosurg 2003;81:5-9.
Field M, Witham TF, Flickinger JC, Kondziolka D, Lunsford D. Comprehensive assessment of hemorrhage risks and outcomes after stereotactic brain biopsy. J Neurosurg 2001;94:545-551.
Kickingereder P, Willeit P, Simon T, Ruge MI. Diagnostic value and safety of stereotactic biopsy for brainstem tumors: a systematic review and meta-analysis of 1480 cases. Neurosurgery 2013;72:873-882.
Hankinson TC, Campagna EJ, Foreman NK, Handler MH. Interpretation of magnetic resonance images in diffuse intrinsic pontine glioma: a survey of pediatric neurosurgeons. J Neurosurg Pediatr 2011;8(1):97-102.
Shakal AAS, Mokbel EAH. Hemorrhage after stereotactic biopsy from intra-axial brain lesions: incidence and avoidance. J Neurol Surg A 2014;75:177-182.
Ferreira MP, Ferreira NP, Pereira Filho Ade A, Pereira Filho Gde A, Franciscatto AC. Stereotactic computed tomography-guided brain biopsy: diagnostic yield based on a series of 170 patients. Surg Neurol 2006;65(Suppl 1):S1:27-S1:32.
Bernstein M, Parrent AG. Complications of CT-guided stereotactic biopsy of intra-axial brain lesions. J Neurosurg 1994;81(2):165-168.
Boviatsis EJ, Kouyialis AT, Stranjalis G, Korfias S, Sakas DE. CTguided stereotactic biopsies of brain stem lesions: personal experience and literature review. Neurol Sci 2003;24:97-102.
Dorward NL, Paleologos TS, Alberti O, Thomas DG. The advantages of frameless stereotactic biopsy over frame-based biopsy. Br J Neurosurg 2002;16:110-118.
Jain D, Sharma MC, Sarkar C, Deb P, Gupta D, Mahapatra AK. Correlation of diagnostic yield of stereotactic brain biopsy with number of biopsy bits and site of the lesión. Brain Tumor Pathol 2006;23:71-75.
Leksell L. A stereotaxic apparatus for intracerebral surgery. Acta Chir Scand 1949;99:229-233.
Kelly PJ. Computer assisted stereotaxis. New approaches for the management of intracranial intra axial tumors. Neurology 1986;36:535-541.
Broggi G, Franzini A, Giorgi C, Allegraza A. Diagnostic accuracy multimodal approach in stereotactic biopsies of deep brain tumors. Acta Neurochirugica (Suppl) 1984;33:211-212.
Kepes JJ. Pitfalls and problems in the histopathologic evaluation of stereotactic needle biopsy specimens. Neurosurg Clin N Am 1994;5:19-33.
Eibach S, Weise L, Setzer M, Seifert V, Senft C. Intraoperative bleeding in stereotactic biopsies and its implication on postoperative management: ¿can we predict CT findings? Stereotact Funct Neurosurg 2014;92:80-85.
Chen C-C, Hsu P-W, Wu T-W, Lee S-T, Chang C-N, Wei K-C et al. Stereotactic brain biopsy: Single center retrospective analysis of complications. Clinical Neurology and Neurosurgery 2009;111:835-839.
Kongkham PN, Knifed E, Tamber MS, Bernstein M. Complications in 622 cases of frame-based stereotactic biopsy, a decreasing procedure. Can J Neurol Sci 2008;3579-84.
Samadani U, Stein S, Moonis G, Sonnad S, Bonura P, Judy K. Stereotactic biopsy of brain stem masses: decision analysis and literature review. Surgical Neurology 2006;66:484-491.
Kulkarni AV, Guha A, Lozano A, Bernstein M. Incidence of silent hemorrhage and delayed deterioration after stereotactic brain biopsy. J Neurosurg 1998;89:31-35.
Di Stefano D, Scucchi LF, Cosentino L, et al. Intraoperative diagnosis of nervous system lesions. Acta Cytol 1998;42:346-56.
Ironside JW, Moss TH, Louis DN, et al. Intraoperative diagnosis. Diagnostic pathology of nervous system tumours. Churchill Livingstone, Elsevier Science Limited 2002;pp.39-52.
Savargaonkar P, Farmer PM. Utility of intra-operative consultations for the diagnosis of central nervous system lesions. Ann Clin Lab Sci 2001;31:133-139.
Folkerth RD. Smears and frozen sections in the intraoperative diagnosis of central nervous system lesions. Neurosurg Clin N Am 1994;5:1-8.
Moss TH, Nicoll JAR, Ironside TW. Intraoperative diagnosis of nervous system tumours. 1997; London: Arnold
Ud Din N, Memon A, Idress R, Ahmad Z, Hasan S. Central nervous system lesions: correlation of intraoperative and final diagnoses, six year experience at a referral centre in a developing country, Pakistan. Asian Pac J Cancer Prev 2011;12(6):1435-1437.
Colbassani HJ, Nishio S, Sweeney KM, et al. CTassisted stereotactic brain biopsy: value of intraoperative frozen section diagnosis. J Neurol Neurosurg Psychiatry 1988;51,332-341.
Regragui A, Amarti Riffi A, Maher M, et al. Accuracy of intraoperative diagnosis in central nervous system tumors: report of 1325 cases. Neurochirurgie 2003;49:67-72.
Heper AO, Erden E, Savas A, Ceyhan K, Erden I, Akyar S, Kanpolat Y. An analysis of stereotactic biopsy of brain tumors and nonneoplastic lesions: a prospective clinicopathologic study. Surg Neurol 2005;64 Suppl 2:S82-8.
Khoddami M, Akbarzadeh A, Mordai A, Bidari-Zerehpoush F, Alipour H, Samadzadeh S, Alipour B. Diagnostic accuracy of frozen section of central nervous system lesions: a 10-year study. Iran J Child Neurol 2015;9(1):25-30.
Somerset HL, Kleinschmidt-DeMasters BK. Approach to the intraoperative consultation for neurosurgical specimens. Adv Anat Pathol 2011;18:446-449.
Plesec TP, Prayson RA. Frozen section discrepancy in the evaluation of central nervous system tumors. Arch Pathol Lab Med 2007;131:1532-1540.
Reyes MG, Homsi MF, McDonald LW, Glick RP. Imprints, smears, and frozen sections of brain tumors. Neurosurgery 1991;29(4):575-579.
Al-Ajmi R, Al-Kindi H, George M, Thomas K. Correlation of intraoperative frozen section report and histopathological diagnosis of central nervous system tumors - A six-year retrospective study. Oman Med J 2016;31(6):414-420.
Kim JE, Kim DG, Paek SH, Jung HW. Stereotactic biopsy for intracranial lesions: reliability and its impact on the planning of treatment. Acta Neurochir (Wien) 2003;145:547-554.
Smith JS, Quiñones-Hinojosa A, Barbaro NM, McDermott MW. Framebased stereotactic biopsy remains an important diagnostic tool with distinct advantages over frameless stereotactic biopsy. J Neurooncol 2005;73:173-179.
Zoeller GK, Benveniste RJ, Landy H, Morcos JJ, Jagid J. Outcomes and management strategies after nondiagnostic stereotactic biopsies of brain lesions. Stereotact Funct Neurosurg 2009;87(3):174-181.
Brainard JA, Prayson RA, Barnett GH. Frozen section evaluation
of stereotactic brain biopsies: diagnostic yield at the stereotactic target position in 188 cases. Arch Pathol Lab Med 1997;121:481-484.
Tofte K, Berger C, Torp SH, Solheim O. The diagnostic properties of frozen sections in suspected intracranial tumors: A study of 578 consecutive cases. Surg Neurol Int 2014;5:170.
Descargas
Publicado
Cómo citar
Número
Sección
Licencia
Derechos de autor 2020 José Leonardo Acosta Quintana
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
